News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Lupin Ltd. (LUPN.BO) Seeks Biosimilar, Lung Drug Partners



3/4/2014 8:24:14 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Indian drugmaker Lupin Ltd is seeking new partnership agreements as it moves into the promising fields of inhaled lung drugs and copies of biotechnology drugs, its managing director said. The United States and Japan were the most interesting regions for so-called "biosimilar" developments by Lupin and the company is actively seeking partners with the right drug development expertise, Nilesh Gupta told Reuters in an interview. Making copies of biotech medicines is emerging as a hot new business area for Indian pharmaceutical companies, which are seeking to move up the value curve by producing more complex and higher-margin generic products.

Help employers find you! Check out all the jobs and post your resume.

Read at Reuters


comments powered by Disqus
Reuters
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES